These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11550123)

  • 21. High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.
    Hervas-Stubbs S; Majlessi L; Simsova M; Morova J; Rojas MJ; Nouzé C; Brodin P; Sebo P; Leclerc C
    Infect Immun; 2006 Jun; 74(6):3396-407. PubMed ID: 16714570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of west nile virus-specific T cell responses in humans.
    Lanteri MC; Heitman JW; Owen RE; Busch T; Gefter N; Kiely N; Kamel HT; Tobler LH; Busch MP; Norris PJ
    J Infect Dis; 2008 May; 197(9):1296-306. PubMed ID: 18422442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
    Westermann J; Nguyen-Hoai T; Mollweide A; Richter G; Schmetzer O; Kim HJ; Blankenstein T; Dörken B; Pezzutto A
    Gene Ther; 2004 Jul; 11(13):1048-56. PubMed ID: 15085174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-inoculation of DNA and protein vaccines induces antigen-specific T cell suppression.
    Kang Y; Jin H; Zheng G; Du X; Xiao C; Zhang X; Geng S; Li X; Wang J; Chen A; Wang B
    Biochem Biophys Res Commun; 2007 Feb; 353(4):1034-9. PubMed ID: 17204242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge.
    Park SU; Kathaperumal K; McDonough S; Akey B; Huntley J; Bannantine JP; Chang YF
    Vaccine; 2008 Aug; 26(34):4329-37. PubMed ID: 18582521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice.
    Voltan R; Castaldello A; Brocca-Cofano E; De Michele R; Triulzi C; Altavilla G; Tondelli L; Laus M; Sparnacci K; Reali E; Gavioli R; Ensoli B; Caputo A
    Vaccine; 2009 Jul; 27(33):4498-507. PubMed ID: 19450649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting DNA vaccines to myeloid cells using a small peptide.
    Ye C; Choi JG; Abraham S; Shankar P; Manjunath N
    Eur J Immunol; 2015 Jan; 45(1):82-8. PubMed ID: 25270431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice.
    Cao F; Li XF; Yu XD; Deng YQ; Jiang T; Zhu QY; Qin ED; Qin CF
    J Virol Methods; 2011 Dec; 178(1-2):87-93. PubMed ID: 21893098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.
    Shrestha B; Ng T; Chu HJ; Noll M; Diamond MS
    Vaccine; 2008 Apr; 26(16):2020-33. PubMed ID: 18339459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice.
    Prow TW; Chen X; Prow NA; Fernando GJ; Tan CS; Raphael AP; Chang D; Ruutu MP; Jenkins DW; Pyke A; Crichton ML; Raphaelli K; Goh LY; Frazer IH; Roberts MS; Gardner J; Khromykh AA; Suhrbier A; Hall RA; Kendall MA
    Small; 2010 Aug; 6(16):1776-84. PubMed ID: 20665754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations.
    Van Hoeven N; Joshi SW; Nana GI; Bosco-Lauth A; Fox C; Bowen RA; Clements DE; Martyak T; Parks DE; Baldwin S; Reed SG; Coler RN
    PLoS One; 2016; 11(2):e0149610. PubMed ID: 26901122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression.
    Douglas MW; Kesson AM; King NJ
    Immunology; 1994 Aug; 82(4):561-70. PubMed ID: 7835918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells.
    Qiao M; Ashok M; Bernard KA; Palacios G; Zhou ZH; Lipkin WI; Liang TJ
    J Infect Dis; 2004 Dec; 190(12):2104-8. PubMed ID: 15551208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.
    Lieberman MM; Clements DE; Ogata S; Wang G; Corpuz G; Wong T; Martyak T; Gilson L; Coller BA; Leung J; Watts DM; Tesh RB; Siirin M; Travassos da Rosa A; Humphreys T; Weeks-Levy C
    Vaccine; 2007 Jan; 25(3):414-23. PubMed ID: 16996661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway.
    Yang JS; Ramanathan MP; Muthumani K; Choo AY; Jin SH; Yu QC; Hwang DS; Choo DK; Lee MD; Dang K; Tang W; Kim JJ; Weiner DB
    Emerg Infect Dis; 2002 Dec; 8(12):1379-84. PubMed ID: 12498651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.